MedTrace Logo

Effect tDCS of Motor Cortex on Chemotherapy Induced Peripheral Neuropathy

NCT04833920 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2021-04-06

No results posted yet for this study

Summary

Chemotherapy induced peripheral neuropathy (CIPN) occurs in conjunction with the use of anticancer medication such as vinca alkaloids (including vincristine), taxanes (including paclitaxel), and platinum preparations (including cisplatin and oxaliplatin)

Conditions

  • Chemotherapy-induced Peripheral Neuropathy

Interventions

DEVICE

transcranial dirrect current brain stimuation

tDCS (2 mA) targeting the primary motor cortex of the contralateral side of the painful side for 20 minute duration for five sessions in five consecutive days (one session /day),

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Shereen M Kamal, Associate Professor · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-01-31
Completion
2022-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04833920 on ClinicalTrials.gov